[Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010752:Phosphoramide Mustards / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D010752:Phosphoramide Mustards; C044331:glyciphosphoramide